EUVIMEDEUVIMED entdecken
Open Access

Development of a specific and sensitive LC–MS/MS method to quantify Heparan Sulfate 3-O-Sulfotransferase-1 activity

Vivien Uyen Doan, Yongmei Xu, Zhangjie Wang, Andrea M Kaminski, Lars C Pedersen, Jian Liu iD

Glycobiology · 2026

DOI: 10.1093/glycob/cwag024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Glycobiology, 2026. Verfasst von Vivien Uyen Doan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, United States. Hauptthemen laut MEDLINE: Sulfotransferases, Tandem Mass Spectrometry, Heparan Sulfate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIH HHS, NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heparan sulfate (HS) is a highly sulfated glycan that regulates diverse biological processes through specific sulfation patterns. Among these, 3-O-sulfation catalyzed by heparan sulfate 3-O-sulfotransferase-1 (3OST-1) is rare but functionally critical, influencing anticoagulation and contributing to the progression of Alzheimer’s disease and cancer progression. However, direct measurement of 3OST-1 activity in biological systems has been limited by the lack of sensitive and specific assays. Here we developed a liquid chromatography–tandem mass spectrometry (LC–MS/MS) assay using a structurally defined HS hexasaccharide substrate and 13C-labeled internal standards. This method enables nanogram-level detection of 3-O-sulfated products following heparinase digestion and AMAC derivatization. The LC–MS/MS assay demonstrated 100-fold improved sensitivity compared to HPLC and successfully quantified endogenous 3OST-1 activity in HCT-116 cells and conditioned media. Using this assay, we confirmed that the 3OST-1 E86Q mutant acts as a dominant-negative inhibitor. E86Q mutant retains substrate and donor binding but abolishes catalytic activity, reducing wild-type 3OST-1-like activity by >80% in vitro and significantly decreasing 3-O-sulfated HS products in cells without affecting overall HS abundance. This assay provides the first quantitative tool for 3OST-1-like activity and establishes a dominant-negative strategy for functional studies, offering new opportunities for biomarker development and therapeutic targeting in HS-related pathologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SulfotransferasesTandem Mass SpectrometryHeparan SulfateHumansLiquid Chromatography-Mass SpectrometryChromatography, Liquid

Stichwörter der Autor:innen

3-OsulfationLC–MSenzyme activity assayheparan sulfatesulfotransferase

Substanzen

SulfotransferasesHeparan Sulfate

Autor:innen und Institutionen

  • Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, United States.
  • Glycan Therapeutics, 617 Hutton Street, Raleigh, NC 27606, United States.
  • Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, United States.

ORCID-Profile: Jian Liu

Förderung

  • NIA NIH HHS
  • NIH HHS
  • NIEHS NIH HHS
  • U.S. Department of Health and Human Services
  • NIH
  • National Institute of Environmental Health Sciences

Zitieren

APA

Doan, V. U., Xu, Y., Wang, Z., Kaminski, A. M., Pedersen, L. C., & Liu, J. (2026). Development of a specific and sensitive LC–MS/MS method to quantify Heparan Sulfate 3-O-Sulfotransferase-1 activity. Glycobiology. https://doi.org/10.1093/glycob/cwag024

Vancouver

Doan VU, Xu Y, Wang Z, Kaminski AM, Pedersen LC, Liu J. Development of a specific and sensitive LC–MS/MS method to quantify Heparan Sulfate 3-O-Sulfotransferase-1 activity. Glycobiology. 2026. doi:10.1093/glycob/cwag024

BibTeX
@article{Doan2026,
  author = {Doan, Vivien Uyen and Xu, Yongmei and Wang, Zhangjie and Kaminski, Andrea M and Pedersen, Lars C and Liu, Jian},
  title = {Development of a specific and sensitive LC–MS/MS method to quantify Heparan Sulfate 3-O-Sulfotransferase-1 activity},
  journal = {Glycobiology},
  year = {2026},
  doi = {10.1093/glycob/cwag024}
}
Kostenlos starten →